236 related articles for article (PubMed ID: 29038344)
1. Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression.
Kim S; Alsaidan OA; Goodwin O; Li Q; Sulejmani E; Han Z; Bai A; Albers T; Beharry Z; Zheng YG; Norris JS; Szulc ZM; Bielawska A; Lebedyeva I; Pegan SD; Cai H
Cancer Res; 2017 Dec; 77(24):6950-6962. PubMed ID: 29038344
[TBL] [Abstract][Full Text] [Related]
2. Myristoylation of Src kinase mediates Src-induced and high-fat diet-accelerated prostate tumor progression in mice.
Kim S; Yang X; Li Q; Wu M; Costyn L; Beharry Z; Bartlett MG; Cai H
J Biol Chem; 2017 Nov; 292(45):18422-18433. PubMed ID: 28939770
[TBL] [Abstract][Full Text] [Related]
3. Suppressors of nmtl-181, a conditional lethal allele of the Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase gene, reveal proteins involved in regulating protein N-myristoylation.
Johnson DR; Cok SJ; Feldmann H; Gordon JI
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10158-62. PubMed ID: 7937855
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
[TBL] [Abstract][Full Text] [Related]
5. A role for Saccharomyces cerevisiae fatty acid activation protein 4 in regulating protein N-myristoylation during entry into stationary phase.
Ashrafi K; Farazi TA; Gordon JI
J Biol Chem; 1998 Oct; 273(40):25864-74. PubMed ID: 9748261
[TBL] [Abstract][Full Text] [Related]
6. N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.
Lodge JK; Jackson-Machelski E; Devadas B; Zupec ME; Getman DP; Kishore N; Freeman SK; McWherter CA; Sikorski JA; Gordon JI
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():357-366. PubMed ID: 9043113
[TBL] [Abstract][Full Text] [Related]
7. Targeting N-myristoylation for therapy of B-cell lymphomas.
Beauchamp E; Yap MC; Iyer A; Perinpanayagam MA; Gamma JM; Vincent KM; Lakshmanan M; Raju A; Tergaonkar V; Tan SY; Lim ST; Dong WF; Postovit LM; Read KD; Gray DW; Wyatt PG; Mackey JR; Berthiaume LG
Nat Commun; 2020 Oct; 11(1):5348. PubMed ID: 33093447
[TBL] [Abstract][Full Text] [Related]
8. Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis.
Ducker CE; Upson JJ; French KJ; Smith CD
Mol Cancer Res; 2005 Aug; 3(8):463-76. PubMed ID: 16123142
[TBL] [Abstract][Full Text] [Related]
9. N-myristoyltransferase-1 deficiency blocks myristoylation of LAMTOR1 and inhibits bladder cancer progression.
Sun Y; Guan Z; Sheng Q; Duan W; Zhao H; Zhou J; Deng Q; Pei X
Cancer Lett; 2022 Mar; 529():126-138. PubMed ID: 34999170
[TBL] [Abstract][Full Text] [Related]
10. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.
Li Q; Ingram L; Kim S; Beharry Z; Cooper JA; Cai H
Neoplasia; 2018 Mar; 20(3):233-243. PubMed ID: 29444487
[TBL] [Abstract][Full Text] [Related]
11. Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines.
Rajala RV; Dehm S; Bi X; Bonham K; Sharma RK
Biochem Biophys Res Commun; 2000 Jul; 273(3):1116-20. PubMed ID: 10891381
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein N-myristoylation: a therapeutic protocol in developing anticancer agents.
Das U; Kumar S; Dimmock JR; Sharma RK
Curr Cancer Drug Targets; 2012 Jul; 12(6):667-92. PubMed ID: 22463587
[TBL] [Abstract][Full Text] [Related]
13. Rapid plasma membrane anchoring of newly synthesized p59fyn: selective requirement for NH2-terminal myristoylation and palmitoylation at cysteine-3.
van't Hof W; Resh MD
J Cell Biol; 1997 Mar; 136(5):1023-35. PubMed ID: 9060467
[TBL] [Abstract][Full Text] [Related]
14. Src activation regulates anoikis in human colon tumor cell lines.
Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
[TBL] [Abstract][Full Text] [Related]
15. NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway.
Deng L; Gao X; Liu B; He X; Xu J; Qiang J; Wu Q; Liu S
Cell Death Dis; 2018 Nov; 9(12):1143. PubMed ID: 30446635
[TBL] [Abstract][Full Text] [Related]
16. N-myristoyltransferase 1 is essential in early mouse development.
Yang SH; Shrivastav A; Kosinski C; Sharma RK; Chen MH; Berthiaume LG; Peters LL; Chuang PT; Young SG; Bergo MO
J Biol Chem; 2005 May; 280(19):18990-5. PubMed ID: 15753093
[TBL] [Abstract][Full Text] [Related]
17. N-myristoylation regulates the SnRK1 pathway in Arabidopsis.
Pierre M; Traverso JA; Boisson B; Domenichini S; Bouchez D; Giglione C; Meinnel T
Plant Cell; 2007 Sep; 19(9):2804-21. PubMed ID: 17827350
[TBL] [Abstract][Full Text] [Related]
18. N-myristoyltransferase.
Rajala RV; Datla RS; Moyana TN; Kakkar R; Carlsen SA; Sharma RK
Mol Cell Biochem; 2000 Jan; 204(1-2):135-55. PubMed ID: 10718634
[TBL] [Abstract][Full Text] [Related]
19. Use of alkyne-tagged myristic acid to detect N-terminal myristoylation.
Xu Y; Lin H
Methods Enzymol; 2023; 684():191-208. PubMed ID: 37230589
[TBL] [Abstract][Full Text] [Related]
20. N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences.
Maurer-Stroh S; Eisenhaber B; Eisenhaber F
J Mol Biol; 2002 Apr; 317(4):523-40. PubMed ID: 11955007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
